Sumitomo Dainippon (Germany) Analysis

Sumitomo Stock Analysis Notes

About 59.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Sumitomo Dainippon Pharma last dividend was issued on the 30th of March 2023. Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. SUMITOMO DAINIPPON operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6140 people. To learn more about Sumitomo Dainippon Pharma call Jonathan Goodman at 81 6 6203 5321 or check out https://www.sumitomo-pharma.com.

Sumitomo Dainippon Pharma Investment Alerts

Sumitomo Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sumitomo Dainippon's market, we take the total number of its shares issued and multiply it by Sumitomo Dainippon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sumitomo Profitablity

The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.

Technical Drivers

As of the 15th of April 2024, Sumitomo Dainippon has the Risk Adjusted Performance of (0.04), coefficient of variation of (1,235), and Variance of 10.73. Sumitomo Dainippon technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Sumitomo Dainippon Pharma, which can be compared to its competition. Please validate Sumitomo Dainippon Pharma maximum drawdown, and the relationship between the information ratio and potential upside to decide if Sumitomo Dainippon is priced more or less accurately, providing market reflects its prevalent price of 2.44 per share.

Sumitomo Dainippon Pharma Price Movement Analysis

Sumitomo Dainippon Predictive Daily Indicators

Sumitomo Dainippon Forecast Models

Sumitomo Dainippon's time-series forecasting models are one of many Sumitomo Dainippon's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sumitomo Dainippon's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sumitomo Dainippon prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sumitomo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sumitomo Dainippon. By using and applying Sumitomo Stock analysis, traders can create a robust methodology for identifying Sumitomo entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Sumitomo Dainippon Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

When running Sumitomo Dainippon's price analysis, check to measure Sumitomo Dainippon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Dainippon is operating at the current time. Most of Sumitomo Dainippon's value examination focuses on studying past and present price action to predict the probability of Sumitomo Dainippon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Dainippon's price. Additionally, you may evaluate how the addition of Sumitomo Dainippon to your portfolios can decrease your overall portfolio volatility.